Ascribe & Microsoft tackle the issue of venous thromboembolism

23rd November 2011 - Ascribe, the leading provider of integrated clinical solutions, announces today that it has undertaken a joint initiative with Microsoft® to tackle the issue of venous thromboembolism (VTE). According to the NHS, VTE causes 25,000 avoidable deaths a year and costs the taxpayer £640m. (http://www.guardian.co.uk/society/2007/apr/20/health) "The All-Party Parliamentary Thrombosis Group (APPTG) has recommended that a CQUIN-compliant electronic VTE risk assessment template is used by clinicians.

Press Release Distribution, Ascribe & Microsoft tackle the issue of venous thromboembolism